Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on Feb...(tics. The Company's internal research an...)

Date:2/5/2008

tics. The Company's internal research and development capabilities, anchored by its proprietary MIDAS(TM) technology, are fueling product development. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. The Company currently has collaborations with AstraZeneca and the Mallinckrodt division of Covidien. For additional information regarding Palatin, please visit Palatin Technologies' website at http://www.palatin.com.

'/>"/>

SOURCE Palatin Technologies, Inc. Copyright©2008 PR Newswire. All rights reserved

1 GOOD

Page: 1 2
Related biology technology :

1. Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007
2. Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007
3. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
4. Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
5. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
6. Intrasphere Technologies Releases PharmaCM Submissions Management and Authoring Module Powered by Microsoft Office SharePoint Server 2007
7. Neurobiological Technologies Sets Date for Second Quarter Financial Results
8. Emisphere Technologies to Present at BIO CEO & Investor Conference on February 12
9. Vestibular Technologies Is Awarded Contract by Major Group Purchasing Organization (GPO)
10. Healthcare Technologies Ltd. Announces the Change of its Name to "NexGen Biofuels Ltd"
11. Genelabs Technologies, Inc. Announces Resignation of President and CEO